Invention Grant
- Patent Title: HCV NS3-NS4 protease resistance mutants
- Patent Title (中): HCV NS3-NS4蛋白酶抗性突变体
-
Application No.: US12272425Application Date: 2008-11-17
-
Publication No.: US07884199B2Publication Date: 2011-02-08
- Inventor: Chao Lin , Kai Lin
- Applicant: Chao Lin , Kai Lin
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07H23/00
- IPC: C07H23/00 ; C12N7/00 ; C12Q1/70
Abstract:
The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.
Public/Granted literature
- US20090191555A1 HCV NS3-NS4 Protease Resistance Mutants Public/Granted day:2009-07-30
Information query
